Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 3011

1.

Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy.

Castro BA, Flanigan P, Jahangiri A, Hoffman D, Chen W, Kuang R, De Lay M, Yagnik G, Wagner JR, Mascharak S, Sidorov M, Shrivastav S, Kohanbash G, Okada H, Aghi MK.

Oncogene. 2017 Feb 20. doi: 10.1038/onc.2017.1. [Epub ahead of print]

PMID:
28218903
2.

Branched-chain amino acids prevent hepatic fibrosis and development of hepatocellular carcinoma in a non-alcoholic steatohepatitis mouse model.

Takegoshi K, Honda M, Okada H, Takabatake R, Matsuzawa-Nagata N, Campbell JS, Nishikawa M, Shimakami T, Shirasaki T, Sakai Y, Yamashita T, Takamura T, Tanaka T, Kaneko S.

Oncotarget. 2017 Feb 13. doi: 10.18632/oncotarget.15304. [Epub ahead of print]

3.

Erratum to: Multicenter Prospective Study on the Safety of Upper Gastrointestinal Endoscopic Procedures in Antithrombotic Drug Users.

Kono Y, Matsubara M, Toyokawa T, Takenaka R, Suzuki S, Nasu J, Yoshioka M, Nakagawa M, Mizuno M, Sakae H, Abe M, Gotoda T, Miura K, Kanzaki H, Iwamuro M, Hori K, Tsuzuki T, Kita M, Kawano S, Kawahara Y, Okada H.

Dig Dis Sci. 2017 Feb 16. doi: 10.1007/s10620-017-4486-1. [Epub ahead of print] No abstract available.

PMID:
28210907
4.

Impact of a Newly Developed Short Double-Balloon Enteroscope on Stent Placement in Patients with Surgically Altered Anatomies.

Tsutsumi K, Kato H, Okada H.

Gut Liver. 2017 Feb 17. doi: 10.5009/gnl16441. [Epub ahead of print]

5.

[Corrigendum] Loss of Runt‑related transcription factor 3 induces resistance to 5‑fluorouracil and cisplatin in hepatocellular carcinoma.

Kataoka J, Shiraha H, Horiguchi S, Sawahara H, Uchida D, Nagahara T, Iwamuro M, Morimoto H, Takeuchi Y, Kuwaki K, Onishi H, Nakamura S, Takaki A, Nouso K, Yagi T, Yamamoto K, Okada H.

Oncol Rep. 2017 Mar;37(3):1921. doi: 10.3892/or.2017.5419.

PMID:
28184917
6.

De Novo Emergence of Mesenchymal Stem-Like CD105+ Cancer Cells by Cytotoxic Agents in Human Hepatocellular Carcinoma.

Nomura Y, Yamashita T, Oishi N, Nio K, Hayashi T, Yoshida M, Hayashi T, Hashiba T, Asahina Y, Okada H, Sunagozaka H, Takatori H, Honda M, Kaneko S.

Transl Oncol. 2017 Feb 6;10(2):184-189. doi: 10.1016/j.tranon.2017.01.005. [Epub ahead of print]

7.

HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium.

Ruiz M, Okada H, Dahlbäck B.

Lipids Health Dis. 2017 Feb 8;16(1):36. doi: 10.1186/s12944-017-0429-2.

8.

Erratum to: Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis.

Komatsu N, Kirito K, Shimoda K, Ishikawa T, Ohishi K, Ohyashiki K, Takahashi N, Okada H, Amagasaki T, Yonezu T, Akashi K.

Int J Hematol. 2017 Mar;105(3):387. doi: 10.1007/s12185-017-2196-2. No abstract available.

PMID:
28176224
9.

Promising therapeutic efficacy of a novel REIC/Dkk-3 expressing adenoviral vector for hepatocellular carcinoma.

Sawahara H, Shiraha H, Uchida D, Kato H, Kato R, Oyama A, Nagahara T, Iwamuro M, Horiguchi S, Tsutsumi K, Mandai M, Mimura T, Wada N, Takeuchi Y, Kuwaki K, Onishi H, Nakamura S, Watanabe M, Sakaguchi M, Takaki A, Nouso K, Yagi T, Nasu Y, Kumon H, Okada H.

J Gastroenterol Hepatol. 2017 Feb 6. doi: 10.1111/jgh.13757. [Epub ahead of print]

PMID:
28168749
10.

Description of LECS from a view point of a surgeon.

Nishizaki M, Okada H, Fujiwara T.

Nihon Shokakibyo Gakkai Zasshi. 2017;114(2):218-223. doi: 10.11405/nisshoshi.114.218. No abstract available.

PMID:
28163286
11.

Cytological features of atypical polypoid adenomyoma of the endometrium: A case report with literature review.

Ebisu Y, Arimoto T, Ishida M, Miyasaka C, Uemura Y, Okada H, Tsuta K.

Diagn Cytopathol. 2017 Feb 4. doi: 10.1002/dc.23665. [Epub ahead of print]

PMID:
28160434
12.

Long-term outcomes and risk factors of biliary stent dysfunction after endoscopic double stenting for malignant biliary and duodenal obstructions.

Matsumoto K, Kato H, Tsutsumi K, Mizukawa S, Yabe S, Seki H, Akimoto Y, Uchida D, Tomoda T, Yamamoto N, Horiguchi S, Kuwaki K, Okada H.

Dig Endosc. 2017 Feb 3. doi: 10.1111/den.12830. [Epub ahead of print]

PMID:
28160331
13.

The Serum Oxidative/Anti-oxidative Stress Balance Becomes Dysregulated in Patients with Non-alcoholic Steatohepatitis Associated with Hepatocellular Carcinoma.

Shimomura Y, Takaki A, Wada N, Yasunaka T, Ikeda F, Maruyama T, Tamaki N, Uchida D, Onishi H, Kuwaki K, Nakamura S, Nouso K, Miyake Y, Koike K, Tomofuji T, Morita M, Yamamoto K, Okada H.

Intern Med. 2017;56(3):243-251. doi: 10.2169/internalmedicine.56.7002.

14.

Utility of serum DNA as a marker for KRAS mutations in pancreatic cancer tissue.

Ako S, Nouso K, Kinugasa H, Dohi C, Matushita H, Mizukawa S, Muro S, Akimoto Y, Uchida D, Tomoda T, Matsumoto K, Horiguchi S, Tsutsumi K, Kato H, Okada H.

Pancreatology. 2016 Dec 27. pii: S1424-3903(16)31258-3. doi: 10.1016/j.pan.2016.12.011. [Epub ahead of print]

PMID:
28139399
15.

Risk of secondary osteoporosis due to lobular cholestasis in non-cirrhotic primary biliary cholangitis.

Seki A, Ikeda F, Miyatake H, Takaguchi K, Hayashi S, Osawa T, Fujioka SI, Tanaka R, Ando M, Seki H, Iwasaki Y, Yamamoto K, Okada H.

J Gastroenterol Hepatol. 2017 Jan 23. doi: 10.1111/jgh.13746. [Epub ahead of print]

PMID:
28114749
16.

Oral Transmission of L-Type Bovine Spongiform Encephalopathy Agent among Cattle.

Okada H, Iwamaru Y, Imamura M, Miyazawa K, Matsuura Y, Masujin K, Murayama Y, Yokoyama T.

Emerg Infect Dis. 2017 Feb;23(2):284-287. doi: 10.3201/eid2302.161416.

17.

Association of New York Heart Association functional class IV symptoms at admission and clinical features with outcomes in patients hospitalized for acute heart failure syndromes.

Asano R, Kajimoto K, Oka T, Sugiura R, Okada H, Kamishima K, Hirata T, Sato N; investigators of the Acute Decompensated Heart Failure Syndromes (ATTEND) registry..

Int J Cardiol. 2017 Mar 1;230:585-591. doi: 10.1016/j.ijcard.2016.12.052.

PMID:
28057363
18.

Effects of a supplement combining Pycnogenol® and l-arginine aspartate on lower urinary dysfunction compared with saw palmetto extract.

Yagi H, Sato R, Nishio K, Arai G, Soh S, Okada H.

J Tradit Complement Med. 2016 Jun 11;7(1):117-120. doi: 10.1016/j.jtcme.2016.05.008.

19.

Multicenter Prospective Study on the Safety of Upper Gastrointestinal Endoscopic Procedures in Antithrombotic Drug Users.

Kono Y, Matsubara M, Toyokawa T, Takenaka R, Suzuki S, Nasu J, Yoshioka M, Nakagawa M, Mizuno M, Sakae H, Abe M, Gotoda T, Miura K, Kanzaki H, Iwamuro M, Hori K, Tsuzuki T, Kita M, Kawano S, Kawahara Y, Okada H.

Dig Dis Sci. 2017 Jan 3. doi: 10.1007/s10620-016-4437-2. [Epub ahead of print] Erratum in: Dig Dis Sci. 2017 Feb 16;:.

PMID:
28050786
20.

Predictive factors for outcomes of patients undergoing endoscopic therapy for bile leak after hepatobiliary surgery.

Yabe S, Kato H, Mizukawa S, Akimoto Y, Uchida D, Seki H, Tomoda T, Matsumoto K, Yamamoto N, Horiguchi S, Tsutsumi K, Okada H.

Dig Endosc. 2016 Dec 29. doi: 10.1111/den.12798. [Epub ahead of print]

PMID:
28032655
Items per page

Supplemental Content

Support Center